SEC Form 4 · accession 0001209191-18-007589
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen M Boudreau
Officer — Chief Financial Officer
Period of report
Feb 1, 2018
Accepted (ET)
Feb 5, 2018 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Feb 1, 2018 | A | 13,759 | A | — | — | Common Stock | 13,759 | 13,759 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
- F2The restricted stock units shall vest in full on February 1, 2019.